- Exchange: Tokyo
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
AnGes MG Inc+ Add to Watchlist
4563:JP342.0 JPY 9.0 2.56%
As of 02:00:00 ET on 08/21/2014.
Company Profile for AnGes MG Inc (4563)
AnGes MG, Inc. develops gene-therapy drugs that use Hepatocyte Growth Factor (HGF) for myocardial infarction and arteriosclerosis patients. The Company also develops nucleic acid drug (decoy oligo) for patients with asthma, allergy, and rheumatism. AnGes MG develops vectors (a carrier used to introduce a foreign gene into a host cell) which help study and analyze genetic functions.
AnGes MG Inc
Key Executives for AnGes MG Inc (4563)
|Ei YamadaPresident/CEO||Shunsuke SamiExecutive Vice President|
|Makoto SekiExecutive Officer||Takahiro NakazawaExecutive Officer|
|Sadayoshi YamanamiExecutive Officer|